How Does the Missing SHOX Gene Cause Short Stature?

In Turner syndrome, one X chromosome is completely or partially missing. This directly leads to short stature because of the loss of a critical gene called SHOX (Short Stature Homeobox). The SHOX gene lives on the ends of the X and Y chromosomes in an area known as the pseudoautosomal region ^[1]. Unlike most genes on the X chromosome, the SHOX gene is not “turned off” in typical females. Therefore, two active copies of the SHOX gene are necessary for normal bone growth ^[1]. When a girl with Turner syndrome has only one copy—a condition called haploinsufficiency—the body does not produce enough of the SHOX protein, which directly limits how much the long bones can grow ^[1].

The Role of SHOX in Bone Development

To understand why missing one SHOX gene has such a profound impact, it helps to look at how bones grow. In children, the long bones (like those in the arms and legs) grow from areas of cartilage near the ends of the bones called growth plates ^[1]. These plates are filled with specialized cells known as chondrocytes (cartilage cells) ^[1].

The SHOX protein acts as a “master switch” or transcription factor, which means it controls the activity of several other genes responsible for bone growth ^[1]. Specifically, SHOX directs the chondrocytes in the growth plates to multiply and mature into larger cells—a process called hypertrophy—which is a crucial step before cartilage hardens into solid bone ^[1].

SHOX promotes this growth through several specific biological pathways:

• Turning down growth inhibitors: SHOX directly represses genes that normally act as brakes on bone growth, allowing the bones to keep lengthening ^[1].
• Turning on growth promoters: SHOX activates genes that encourage growth-promoting signals within the bone tissue ^[1].
• Building the cartilage matrix: SHOX works alongside other proteins to produce vital structural components of the cartilage in the growth plate ^[1].

What Happens Without Enough SHOX?

When only one copy of the SHOX gene is present, there simply isn’t enough SHOX protein to keep the growth plate functioning optimally ^[1]. The chondrocytes do not mature and organize as well as they should ^[1]. This leads to a slower overall growth rate and can sometimes cause mesomelic short stature, where the middle parts of the limbs (like the forearms and lower legs) are slightly shorter in proportion to the rest of the body ^[1]. In Turner syndrome, this difference in proportion is usually subtle and rarely requires orthopedic treatment.

During typical puberty, the natural production of estrogen eventually causes the growth plates to close and stop growing. Because girls with Turner syndrome are often estrogen-deficient, their growth plates can sometimes stay open longer ^[1]. However, it is important to know that estrogen replacement therapy is still a critical part of standard Turner syndrome care for inducing puberty and protecting long-term bone health. Endocrinologists carefully time both growth hormone and estrogen therapies to balance optimizing adult height with ensuring appropriate pubertal development.

Why Growth Hormone Therapy is the Standard of Care

Because the short stature in Turner syndrome is caused by a genetic mechanism that directly limits the natural growth of long bones, taking nutritional supplements or waiting for a “growth spurt” will not significantly change the outcome.

Instead, growth hormone (GH) therapy is the standard, clinically proven treatment to overcome the effects of SHOX haploinsufficiency ^[2][3]. While GH does not fix the missing gene, it bypasses the problem by strongly stimulating the growth plates to multiply and grow through different biological pathways ^[1].

Clinical evidence shows that daily GH therapy, which is administered via subcutaneous injections (small shots just under the skin), is highly effective for girls with Turner syndrome, often adding an average of 8 to 9 centimeters to a patient’s final adult height ^[1]. Starting treatment early is one of the strongest predictors for achieving an adult height closer to the typical range ^[4][5].